SPX -0.62% VIX 6.80%
FED'S ROSENGREN SAYS ECONOMY DOESN'T LOOK LIKE IT NEEDS INTEREST-RATE CUT 
U.S. STOCKS END LOWER AS EXPECTATIONS FOR HALF-POINT RATE CUT WANE 
STOCKS HAVE TURNED NEGATIVE IN THE FINAL HOUR OF TRADING FRIDAY 
DISNEY'S LIVE-ACTION 'LION KING' SHOULD RULE THE MOVIE WORLD ON THIS HOT WEEKEND 
YOU CAN NOW BUY TRUMP-BRANDED STRAWS TO COUNTER THE 'LIBERAL' PAPER VERSIONS 
DEEP DIVE: BIG-BANK EARNINGS POINT TO NEAR-TERM PAIN AND LONG-TERM OPPORTUNITY 
CONSUMERS REMAIN UPBEAT ABOUT U.S. ECONOMY, UNIV. OF MICH. DATA SHOW 
'RELIEF' RALLY IN BOEING A KEY FACTOR IN KEEPING DOW IN POSITIVE TERRITORY 
RED ROBIN SHARES SOAR AFTER ACTIVIST-INVESTOR OFFER 
MICROSOFT HITS ALL-TIME INTRADAY HIGH AS IT JOINS BOEING IN PACING DOW ADVANCE 
Sat, Jul 20 6:36pm


Fate Therapeutics Inc [FATE]
$21.37 1.13 (5.02%)

FATE Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 1.45 Billion
FATE Description

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.


Visit Website

FATE Earnings

EPS -0.30 P/E Ratio 0.00
Previous Earnings Tue, Mar 5, 2019
Latest Earnings Tue, May 7, 2019 (74 days ago) +19.32%

FATE Dividend

Yield --
Ex-Date --
Pay Date --
History --

FATE Charts

$8.66
52 Week Range
$22.63
Jul 30, 2018
Jul 18, 2019



Symbol Price Day % YTD %
FATE $21.37 -5.02% 57.95%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy